Cellectis Adr (CLLS)

Aug 13, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal moment - Investing.com

Aug 13, 2025

Aug 05, 2025

Earnings call transcript: Cellectis Q2 2025 earnings miss drives stock down 13% - Investing.com

Aug 05, 2025

Aug 04, 2025

Cellectis earnings missed by $0.02, revenue topped estimates - Investing.com India

Aug 04, 2025

Aug 04, 2025

Cellectis earnings missed by $0.02, revenue topped estimates By Investing.com - Investing.com South Africa

Aug 04, 2025

Aug 01, 2025

European Stocks Dip As US Holders Turn Cautious - Finimize

Aug 01, 2025

Jul 28, 2025

Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks With ‘Strong Buy’ Ratings - Barchart.com

Jul 28, 2025

Jul 24, 2025

European ADRs Inch Higher As Drugmakers Shine - Finimize

Jul 24, 2025

Jul 21, 2025

Cellectis shares surge 66% following InvestingPro’s April Fair Value alert By Investing.com - Investing.com India

Jul 21, 2025

Jul 16, 2025

European Stocks Falter On Wall Street As ADR Index Drops - Finimize

Jul 16, 2025

Jul 03, 2025

European Equities Slip While Biopharma Stocks Shine - Finimize

Jul 03, 2025

Jun 16, 2025

European Stocks Shine As ADRs Climb Higher - Finimize

Jun 16, 2025

Jun 13, 2025

European ADRs Dip With Some Stocks Rising Above The Crowd - Finimize

Jun 13, 2025

May 26, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year By Investing.com - Investing.com South Africa

May 26, 2025

May 26, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year - Investing.com

May 26, 2025

May 21, 2025

Cellectis S.A. announces board change and meeting By Investing.com - Investing.com India

May 21, 2025

May 21, 2025

Cellectis S.A. announces board change and meeting - Investing.com

May 21, 2025

May 15, 2025

European Equities See Growth In US Trade - Finimize

May 15, 2025

May 13, 2025

Cellectis earnings beat by $0.07, revenue topped estimates - Investing.com

May 13, 2025

May 12, 2025

Cellectis earnings beat by $0.06, revenue topped estimates - Investing.com India

May 12, 2025

Apr 22, 2025

Cellectis Charts Course For 2025 With Boost From AstraZeneca Deal - Barchart.com

Apr 22, 2025

Apr 11, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView

Apr 11, 2025

Apr 08, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Apr 08, 2025

Apr 04, 2025

Cellectis stock touches 52-week low at $1.14 amid market challenges - Investing.com

Apr 04, 2025

Apr 02, 2025

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - TradingView

Apr 02, 2025

Mar 20, 2025

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - TradingView

Mar 20, 2025

Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025

Mar 17, 2025

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - TradingView

Mar 17, 2025

Mar 17, 2025

Cellectis’s SWOT analysis: biotech firm’s stock faces CAR T challenges - Investing.com

Mar 17, 2025

Mar 15, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% By Investing.com - Investing.com South Africa

Mar 15, 2025

Mar 14, 2025

Cellectis stock touches 52-week low at $1.2 amid market challenges - Investing.com India

Mar 14, 2025

Mar 14, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% - Investing.com India

Mar 14, 2025

Mar 14, 2025

What Recent Market Trends Mean for Cosan S.A ADR’s (CSAN) Stock - The News Heater

Mar 14, 2025

Mar 11, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 11, 2025